Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297 GBX | +0.68% | -8.05% | -15.74% |
Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Bullish |
Resistance | 323.00 | 420.00 | 420.00 |
Spread/Res. | -9.88% | -30.69% | -30.69% |
Spread/Supp. | +1.25% | +9.85% | -0.48% |
Support | 287.50 | 265.00 | 292.50 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- MXCT Stock
- Charts MaxCyte, Inc.